Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade PMID 42321916
View analysis →A grade PMID 42690647
View analysis →A grade PMID 42372741
View analysis →A grade PMID 42216567
View analysis →A grade PMID 41916649
View analysis →A grade PMID 42382416
View analysis →A grade PMID 42150584
View analysis →B grade PMID 42748428
View analysis →A grade PMID 41756844
View analysis →A grade PMID 42765973
View analysis →A grade PMID 42362103
View analysis →A grade PMID 42101908
View analysis →Green-synthesized Ficus benghalensis-derived ZnO nanoparticles inhibited Saos-2 osteosarcoma cell proliferation at an reported IC50 of 75 μg/mL and were associated with oxidative stress, G0/G1 arrest, and apoptotic markers.
The supplied in-vitro evidence shows cytotoxic and apoptosis-associated effects in one osteosarcoma cell line; it supports the hypothesis—but does not establish—that these ZnO nanoparticles or their active features could be developed into an osteosarcoma therapy if selectivity, delivery, safety, reproducibility, and in-vivo efficacy are demonstrated.
This systematic review and meta-analysis of 3,883 patients found that non-operative management of uncomplicated appendicitis had a pooled long-term failure rate of 38.9%, a subsequent appendectomy rate of 36.3%, cost savings versus surgery, and an approximately 0.3% incidence of appendiceal neoplasms.
The evidence supports using long-term failure and subsequent appendectomy risk when comparing non-operative management with surgery; it only indirectly suggests that rare appendiceal neoplasms might warrant consideration, because oncology-specific outcomes, pediatric subgroup results, and risk-stratification data are not provided.
This 17-year, single-center retrospective study describes tumor sites, histopathology, and treatment patterns among 52 children and adolescents with oral and maxillofacial malignancies, most of whom underwent surgery.
The record shows that surgical approaches varied by pathological type; it is reasonable—but not demonstrated here—to hypothesize that pathology-guided multidisciplinary planning could improve tumor control while limiting growth-related morbidity, because no survival, recurrence, functional, developmental, or toxicity outcomes are reported.
This single-center retrospective MENA-region study of 220 patients reports that adolescents and young adults with Philadelphia-negative myeloproliferative neoplasms differed from older adults in risk classification, molecular profiles, and thrombotic phenotype, but not overall survival.
The study provides observational evidence of age-associated clinical and molecular differences; it supports the hypothesis, but does not demonstrate, that AYA-specific risk assessment or treatment-selection strategies could improve management of Philadelphia-negative MPNs.
Interviews with 12 survivorship clinicians identified communication barriers—including information burden, limited time, and anxiety—and strategies such as rapport building, accessible language, visual aids, and contextualization of risk and uncertainty in AYA cancer survivorship care.
The study provides qualitative evidence that clinicians perceive tailored, clear, rapport-based communication as supportive of AYA engagement; it remains an untested inference that formal communication interventions or clinician training based on these themes would improve adherence, psychosocial well-being, or long-term health outcomes.
In a retrospective MRI case-control study of 811 patients with histologically confirmed gliomas or glioneuronal and neuronal tumors and 744 controls, normalized choroid plexus volume was associated mainly with tumor location and histological classification rather than grade, with an exploratory association between +7/−10 status and lower volume.
The evidence supports choroid plexus volume as a potential imaging correlate of tumor location and classification; it is only an inference that validated CPV patterns might eventually aid noninvasive tumor characterization or patient stratification, and the record provides no evidence that CPV is a therapeutic target or predicts treatment response or outcome.
This structured narrative review reports that pediatric retractile testes may be associated with acquired cryptorchidism, torsion, atrophy, and impaired fertility, but the predominantly retrospective and observational evidence supports continued surveillance rather than routine orchiopexy.
The reviewed evidence supports structured follow-up to detect testicular ascent or atrophy and apply established surgical indications promptly; it remains an inference, not demonstrated by comparative prospective evidence, that intensified surveillance or earlier intervention would improve fertility, prevent torsion, or affect malignancy risk.
In a retrospective series of 85 patients aged 4-80 years undergoing CT-guided localization before VATS, both spiral-wire and hydrogel-plug markers achieved 100% technical positioning success, while spiral-wire was associated with less reported displacement and parenchymal hemorrhage.
The evidence supports both devices as feasible localization tools in this mixed-age surgical series; it is reasonable but unproven to infer that choosing the more stable marker could improve resection targeting and reduce procedure-related injury, particularly because pediatric-specific outcomes and effects on cancer control were not reported.
In a retrospective pediatric CNO cohort, whole-body MRI identified more skeletal lesions than regional MRI, while presenting symptoms did not correlate with imaging-defined disease burden.
The evidence supports whole-body MRI as a method for detecting otherwise occult CNO lesions; it is reasonable but unproven to infer that earlier systematic imaging could improve diagnostic classification, reduce delays, or guide management, particularly when infection or malignancy is being considered.
This systematic review of 46 published adult cases found that isolated lesser trochanter fractures were frequently associated with malignancy in the selected literature and often preceded recognition of the cancer, while emphasizing that these proportions are not population prevalence estimates.
The evidence supports isolated lesser trochanter fracture as a possible diagnostic warning sign in skeletally mature adults; it can only be inferred—not established—that prompt evaluation of suspicious fractures might enable earlier cancer detection or treatment planning, and the record provides no pediatric or therapeutic-outcome evidence.
In a retrospective cohort with caregiver telephone questionnaires for 127 adolescents and young men after childhood orchiopexy, only 4.7% reported monthly testicular self-examination, with limited documented or recalled counseling and lack of instruction identified as the most common barrier.
The evidence identifies a post-orchiopexy education and follow-up gap; it is reasonable but unproven to hypothesize that structured adolescent transition counseling and primary-care communication could improve self-examination adherence, while this study does not show earlier cancer detection or improved clinical outcomes.
This observational initiative reviewed pediatric cancer pathology cases across centers in Syria, Lebanon, and the United States, finding clinically important diagnostic discrepancies and identifying training, immunohistochemistry, laboratory-process, and reporting needs.
Evidence: regional pathology review detected major diagnostic discrepancies in 17% of cases with a regional final diagnosis and identified actionable capacity gaps. Inference: correcting these gaps could improve treatment selection and patient safety by reducing pediatric cancer misclassification, although treatment changes and patient outcomes were not reported.
